XML 35 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STATEMENTS OF CHANGES IN PREFERRED STOCK AND STOCKHOLDERS' Equity (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital Common Stock
Accumulated Deficit
Series 1 Preferred Stock - Mezzanine
Balance at Dec. 31, 2016 $ (77,298) $ 132 $ 580,567 $ (657,997) $ 125,321
Balance (in shares) at Dec. 31, 2016   132,376,670     106,184
Adjustment for implementation of ASU No. 2014-09, Revenue from Contracts with Customers     122 (122)  
Stock-based compensation 8,454   8,454    
Issuance of restricted common stock   $ 1 (1)    
Issuance of restricted common stock (in shares)   907,032      
Exercise of employee stock options $ 88 $ 1 87    
Exercise of employee stock options (in shares) 180,000 59,864      
Repurchase of restricted common stock $ (2,059) $ (1) (2,058)    
Repurchase of restricted common stock (Shares)   (394,267)      
Issuance of common stock in connection with at the market offering, net 47,270 $ 10 47,260    
Issuance of common stock in connection with at the market offering, net (in shares)   9,708,738      
Preferred stock dividends         $ 18,672
Preferred stock dividends (18,938)   (18,938)    
Preferred stock dividends (in shares)         13,460
Net loss (54,323)     (54,323)  
Balance at Dec. 31, 2017 (96,806) $ 143 615,493 (712,442) $ 143,993
Balance (in shares) at Dec. 31, 2017   142,658,037     119,644
Adjustment for implementation of ASU No. 2014-09, Revenue from Contracts with Customers (8,131)     (8,131)  
Stock-based compensation 7,534   7,534    
Issuance of restricted common stock 1 $ 2 (1)    
Issuance of restricted common stock (in shares)   150,321      
Exercise of employee stock options $ 242 $ 2 240    
Exercise of employee stock options (in shares) 104,167 104,166      
Cancelled restricted common stock $ 1 $ (2) 3    
Cancelled restricted common stock (in shares)   (271,433)      
Repurchase of restricted common stock (1,624) $ (3) (1,621)    
Repurchase of restricted common stock (Shares)   (514,349)      
Issuance of common stock in connection with at the market offering, net 47,101 $ 19 47,082    
Issuance of common stock in connection with at the market offering, net (in shares)   18,939,394      
Preferred stock dividends         $ 16,775
Preferred stock dividends (16,998)   (16,998)    
Preferred stock dividends (in shares)         11,415
Settlement of a related party relationship (Note 7) 207,361     207,361 $ (160,767)
Settlement of a related party relationship (Note 7) (in shares)         (131,059)
Net loss (53,117)     (53,117)  
Balance at Dec. 31, 2018 85,564 $ 161 651,732 (566,329)  
Balance (in shares) at Dec. 31, 2018   161,066,136      
Stock-based compensation 6,341   6,341    
Issuance of restricted common stock 1,000 $ 2 998    
Issuance of restricted common stock (in shares)   1,519,766      
Exercise of employee stock options $ 1,219   1,219    
Exercise of employee stock options (in shares) 581,105 443,051      
Cancelled restricted common stock (in shares)   (74,599)      
Issuance of common stock upon exercise of warrants, net $ 60,751   60,751    
Repurchase of restricted common stock (653)   (653)    
Repurchase of restricted common stock (Shares)   (225,339)      
Issuance of common stock in connection with at the market offering, net $ 6,085 $ 1 6,084    
Issuance of common stock in connection with at the market offering, net (in shares) 2,814,673 1,271,274      
Warrant exercise, net of commissions and expenses of $1.1 million $ 52,499 $ 18 52,481    
Warrant exercise, net of commissions and expenses of $1.1 million (in shares)   17,803,031      
Net loss (117,796)     (117,796)  
Balance at Dec. 31, 2019 $ 95,010 $ 182 $ 778,953 $ (684,125)  
Balance (in shares) at Dec. 31, 2019   181,803,320